Analyze Diet
Journal of equine science2015; 26(1); 15-20; doi: 10.1294/jes.26.15

Anti-Müllerian hormone as an indicator of hemi-castrated unilateral cryptorchid horses.

Abstract: Anti-Müllerian hormone (AMH), a glycoprotein secreted from the fetal testis, is responsible for regression of the Müllerian duct in the male fetus. The aim of this study was to evaluate the usefulness of serum AMH as a biomarker for diagnosis of cryptorchidism in horses. Serum AMH concentrations were measured in intact stallions, hemi-castrated unilateral cryptorchid stallions, and geldings. In addition, expression of AMH was characterized in cryptorchid testes by immunohistochemistry. Serum AMH was detected in intact stallions (n=11, 13.3 ± 1.8 ng/ml) and in hemi-castrated cryptorchid stallions (n=8, 17.6 ± 3.0 ng/ml), but not in geldings (n=6, all data were below the limit of detection). Immunolabeling for AMH was detected in Sertoli cells of undescended testes from cryptorchid horses as well as those of normal testes. Our findings indicate that the cryptorchid testis after hemi-castration secretes AMH and that serum AMH concentrations may be a useful biomarker for diagnosis of equine cryptorchidism.
Publication Date: 2015-03-31 PubMed ID: 25829866PubMed Central: PMC4379328DOI: 10.1294/jes.26.15Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates the use of Anti-Müllerian hormone (AMH), a glycoprotein secreted from the testis, as a biomarker to diagnose cryptorchidism (a condition where one or both of the testes fail to descend) in horses, particularly in case of hemi-castrated unilateral cryptorchid stallions.

Objective and Methodology of the Research

  • The research aimed at evaluating Anti-Müllerian hormone (AMH) as a potential biomarker for diagnosing cryptorchidism in horses. Cryptorchidism is a condition in male animals where one or both testes fail to descend into the scrotum before birth.
  • The scientists collected and measured the serum AMH concentrations in three sets – intact stallions, hemi-castrated unilateral cryptorchid stallions (those with only one undescended testicle), and geldings (castrated males).
  • The team carried out an immunohistochemistry (a method used to visualize certain proteins in cells of a tissue) to characterize the expression of AMH in the cryptorchid testes.

Key Findings

  • AMH was detected in serum samples collected from both intact stallions and hemi-castrated cryptorchid stallions, but not in geldings. This indicates that AMH is secreted in the bloodstream only when testes are present, either descended or undescended.
  • The results showed the immunolabeling for AMH in Sertoli cells of cryptorchid horses’ testes as well as in normal testes. This suggested that cryptorchid testis continues to secrete AMH, even after hemi-castration (removal of one testicle).

Conclusion

  • The researchers concluded that serum AMH concentrations could serve as a useful biomarker for diagnosing cryptorchidism in horses. This finding adds insight into equine reproductive physiology and could have implications in veterinary medicine to better understand and manage cryptorchidism in horses.

Cite This Article

APA
Murase H, Saito S, Amaya T, Sato F, Ball BA, Nambo Y. (2015). Anti-Müllerian hormone as an indicator of hemi-castrated unilateral cryptorchid horses. J Equine Sci, 26(1), 15-20. https://doi.org/10.1294/jes.26.15

Publication

ISSN: 1340-3516
NlmUniqueID: 9503751
Country: Japan
Language: English
Volume: 26
Issue: 1
Pages: 15-20

Researcher Affiliations

Murase, Harutaka
  • Equine Science Division, Hidaka Training and Research Center, Japan Racing Association, Hokkaido 057-0171, Japan.
Saito, Shigeaki
  • Yamato Kohgen Animal Medical Clinic, Osaka 583-0867, Japan.
Amaya, Tomohiko
  • Yamato Kohgen Animal Medical Clinic, Osaka 583-0867, Japan.
Sato, Fumio
  • Equine Science Division, Hidaka Training and Research Center, Japan Racing Association, Hokkaido 057-0171, Japan.
Ball, Barry Allen
  • Reproduction Laboratory, The Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY, U.S.A.
Nambo, Yasuo
  • Equine Science Division, Hidaka Training and Research Center, Japan Racing Association, Hokkaido 057-0171, Japan ; Present address: Department of Clinical Veterinary Sciences, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido 080-8555, Japan.

References

This article includes 21 references
  1. Aksglaede L, Sørensen K, Boas M, Mouritsen A, Hagen C.P, Jensen R.B, Petersen J.H, Linneberg A, Andersson A.M, Main K.M, Skakkebæk N.E, Juul A. Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J. Clin. Endocrinol. Metab. 95: 5357–5364.
    pubmed: 20843948
  2. Almeida J, Conley A.J, Mathewson L, Ball B.A. Expression of anti-Müllerian hormone, cyclin-dependent kinase inhibitor (CDKN1B), androgen receptor, and connexin 43 in equine testes during puberty. Theriogenology 77: 847–857.
    pubmed: 22115811
  3. Arighi M. Testicular descent. pp. 1099–1106. In: Equine Reproduction, Vol. 1, 2nd ed. (McKinnon, A.O., et al. eds.), Blackwell Publishing, West Sussex.
  4. Arighi M, Bosu W. Comparison of hormonal methods for diagnosis in horses. J. Equine Vet. Sci. 9: 20–26.
  5. Baker M.L, Hutson J.M. Serum levels of mullerian inhibiting substance in boys throughout puberty and in the first two years of life. J. Clin. Endocrinol. Metab. 76: 245–247.
    pubmed: 8421093
  6. Ball B.A, Conley A.J, Grundy S.A, Sabeur K, Liu I.K. Expression of anti-Müllerian hormone (AMH) in the equine testis. Theriogenology 69: 624–631.
    pubmed: 18242669
  7. Bergin W.C, Gier H.T, Marion G.B, Coffman J.R. A developmental concept of equine cryptorchism. Biol. Reprod. 3: 82–92.
    pubmed: 4398874
  8. Claes A, Ball B.A, Almeida J, Corbin C.J, Conley A.J. Serum anti-Müllerian hormone concentrations in stallions: developmental changes, seasonal variation, and differences between intact stallions, cryptorchid stallions, and geldings. Theriogenology 79: 1229–1235.
    pubmed: 23591325
  9. Cox J.E. Experiences with a diagnostic test for equine cryptorchidism. Equine Vet. J. 7: 179–183.
  10. Guibourdenche J, Lucidarme N, Chevenne D, Rigal O, Nicolas M, Luton D, Léger J, Porquet D, Noël M. Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol. Cell. Endocrinol. 211: 55–63.
    pubmed: 14656477
  11. Jann H.W, Rains J.R. Diagnostic ultrasonography for evaluation of cryptorchidism in horses. J. Am. Vet. Med. Assoc. 196: 297–300.
    pubmed: 1967599
  12. Josso N, Cate R.L, Picard J.Y, Vigier B, di Clemente N, Wilson C, Imbeaud S, Pepinsky R.B, Guerrier D, Boussin L, Legeal L, Carreeusebe D. Anti-Müllerian hormone: the Jost factor. Recent Prog. Horm. Res. 48: 1–59.
    pubmed: 8441845
  13. Jost A. Problems of fetal endocrinology: the gonadal and hypophyseal hormones. Recent Prog. Horm. Res. 8: 379–418.
    pubmed: 5334634
  14. Lee M.M, Donahoe P.K, Hasegawa T, Silverman B, Crist G.B, Best S, Hasegawa Y, Noto R.A, Schoenfeld D, MacLaughlin D.T. Müllerian inhibiting substance in humans: normal levels from infancy to adulthood. J. Clin. Endocrinol. Metab. 81: 571–576.
    pubmed: 8636269
  15. Lee M.M, Donahoe P.K, Silverman B.L, Hasegawa T, Hasegawa Y, Gustafson M.L, Chang Y.C, MacLaughlin D.T. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. N. Engl. J. Med. 336: 1480–1486.
    pubmed: 9154766
  16. Lee M.M, Misra M, Donahoe P.K, MacLaughlin D.T. MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol. Cell. Endocrinol. 211: 91–98.
    pubmed: 14656481
  17. Mueller P.O.E, Parks A.H. Cryptorchidism in horses. Equine Vet. Educ. 11: 77–86.
  18. Rey R, Lukas-Croisier C, Lasala C, Bedecarrás P. AMH/MIS: what we know already about the gene, the protein and its regulation. Mol. Cell. Endocrinol. 211: 21–31.
    pubmed: 14656472
  19. Stickle R.L, Fessler J.F. Retrospective study of 350 cases of equine cryptorchidism. J. Am. Vet. Med. Assoc. 172: 343–346.
    pubmed: 23371
  20. Wallace A.M, Faye S.A, Fleming R, Nelson S.M. A multicentre evaluation of the new Beckman Coulter anti-müllerian hormone immunoassay (AMH Gen II). Ann. Clin. Biochem. 48: 370–373.
    pubmed: 21628625
  21. Williams W.L. Diseases of the Genital Organs of Domestic Animals. 3rd ed., Ethel Williams Plimpton Publishing Co., Massachusetts.